Megan E. Wolf, Daniel J. Hinchen, Michael Zahn, John E. McGeehan, Lindsay D. Eltis
{"title":"Engineering a Cytochrome P450 O-Demethylase for the Bioconversion of Hardwood Lignin","authors":"Megan E. Wolf, Daniel J. Hinchen, Michael Zahn, John E. McGeehan, Lindsay D. Eltis","doi":"10.1021/acssynbio.6c00337","DOIUrl":null,"url":null,"abstract":"<p>Lignin is a sustainable alternative\r\nto petroleum as a feedstock\r\nfor the chemical industry. Emergent strategies for lignin valorization\r\ninvolve tandem processes in which biomass is chemo-catalytically fractionated,\r\nfollowed by bioconversion of the depolymerized lignin by microbial\r\ncell factories. A rate-limiting step in this bioconversion is <em>O</em>-demethylation of the lignin-derived monomers. The reductive\r\ncatalytic fractionation of hardwood biomass generates high yields\r\nof two classes of monomers: 4-alkylguaiacols and 4-alkylsyringols.\r\nThe former are <em>O-</em>demethylated by AgcA, a cytochrome\r\nP450, and AgcB, the cognate reductase, but there are no known enzymes\r\nthat convert the latter. To develop a biocatalyst that can efficiently\r\ntransform these monomers, we studied and rationally engineered AgcAB.\r\nA 1.82 Å resolution crystal structure of AgcA<sub>EP4</sub> from <em>Rhodococcus rhodochrous</em> EP4 in complex with 4-ethylguaiacol\r\nidentified residues Leu78, Ala293, and Phe166 as potential specificity\r\ndeterminants. Substitution of Ala293 and Leu78 decreased the specificity\r\nof AgcA<sub>EP4</sub> for alkylguaiacols. Substitution of Phe166 yielded\r\na variant that bound 4-propylsyringol but did not transform it. In\r\ncontrast, the corresponding variant in the <em>Rhodococcus aromaticivorans</em> RHA1 homologue, AgcA<sub>RHA1</sub> Y166A, catalyzed the <em>O</em>-demethylation of both methoxy\r\ngroups of 4-propylsyringol with a <em>k</em><sub>cat</sub><em>/K</em><sub>m</sub> of 8500 M<sup>–1</sup> s<sup>–1</sup> for the first <em>O</em>-demethylation, nearly\r\n7-fold higher than WT AgcA<sub>RHA1</sub>. Engineering RHA1 to express\r\nthe variant yielded a strain that transformed 4-propylsyringol and\r\n4-propylguaiacol simultaneously. Moreover, the engineered strain converted\r\nsome of the 4-propylsyringol to pentanoyl-CoA, consistent with catabolism\r\nvia the <em>meta</em>-cleavage pathway that catabolizes 4-alkylguaiacols.\r\nExometabolomics validated the conversion of 4-propylsyringol via this\r\npathway and identified <em>O</em>-demethylation and extradiol\r\nring cleavage as bottlenecks for its transformation. These studies\r\nimprove our understanding of a critical lignin-degrading enzyme system\r\nand significantly advance the development of a biocatalyst to convert\r\nthese monomers.</p>","PeriodicalId":26,"journal":{"name":"ACS Synthetic Biology","volume":"15 8","pages":"3449–3461"},"PeriodicalIF":4.5000,"publicationDate":"2026-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Synthetic Biology","FirstCategoryId":"99","ListUrlMain":"https://pubs.acs.org/doi/10.1021/acssynbio.6c00337","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/7/6 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"BIOCHEMICAL RESEARCH METHODS","Score":null,"Total":0}
引用次数: 0
Abstract
Lignin is a sustainable alternative
to petroleum as a feedstock
for the chemical industry. Emergent strategies for lignin valorization
involve tandem processes in which biomass is chemo-catalytically fractionated,
followed by bioconversion of the depolymerized lignin by microbial
cell factories. A rate-limiting step in this bioconversion is O-demethylation of the lignin-derived monomers. The reductive
catalytic fractionation of hardwood biomass generates high yields
of two classes of monomers: 4-alkylguaiacols and 4-alkylsyringols.
The former are O-demethylated by AgcA, a cytochrome
P450, and AgcB, the cognate reductase, but there are no known enzymes
that convert the latter. To develop a biocatalyst that can efficiently
transform these monomers, we studied and rationally engineered AgcAB.
A 1.82 Å resolution crystal structure of AgcAEP4 from Rhodococcus rhodochrous EP4 in complex with 4-ethylguaiacol
identified residues Leu78, Ala293, and Phe166 as potential specificity
determinants. Substitution of Ala293 and Leu78 decreased the specificity
of AgcAEP4 for alkylguaiacols. Substitution of Phe166 yielded
a variant that bound 4-propylsyringol but did not transform it. In
contrast, the corresponding variant in the Rhodococcus aromaticivorans RHA1 homologue, AgcARHA1 Y166A, catalyzed the O-demethylation of both methoxy
groups of 4-propylsyringol with a kcat/Km of 8500 M–1 s–1 for the first O-demethylation, nearly
7-fold higher than WT AgcARHA1. Engineering RHA1 to express
the variant yielded a strain that transformed 4-propylsyringol and
4-propylguaiacol simultaneously. Moreover, the engineered strain converted
some of the 4-propylsyringol to pentanoyl-CoA, consistent with catabolism
via the meta-cleavage pathway that catabolizes 4-alkylguaiacols.
Exometabolomics validated the conversion of 4-propylsyringol via this
pathway and identified O-demethylation and extradiol
ring cleavage as bottlenecks for its transformation. These studies
improve our understanding of a critical lignin-degrading enzyme system
and significantly advance the development of a biocatalyst to convert
these monomers.
期刊介绍:
The journal is particularly interested in studies on the design and synthesis of new genetic circuits and gene products; computational methods in the design of systems; and integrative applied approaches to understanding disease and metabolism.
Topics may include, but are not limited to:
Design and optimization of genetic systems
Genetic circuit design and their principles for their organization into programs
Computational methods to aid the design of genetic systems
Experimental methods to quantify genetic parts, circuits, and metabolic fluxes
Genetic parts libraries: their creation, analysis, and ontological representation
Protein engineering including computational design
Metabolic engineering and cellular manufacturing, including biomass conversion
Natural product access, engineering, and production
Creative and innovative applications of cellular programming
Medical applications, tissue engineering, and the programming of therapeutic cells
Minimal cell design and construction
Genomics and genome replacement strategies
Viral engineering
Automated and robotic assembly platforms for synthetic biology
DNA synthesis methodologies
Metagenomics and synthetic metagenomic analysis
Bioinformatics applied to gene discovery, chemoinformatics, and pathway construction
Gene optimization
Methods for genome-scale measurements of transcription and metabolomics
Systems biology and methods to integrate multiple data sources
in vitro and cell-free synthetic biology and molecular programming
Nucleic acid engineering.